BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17890905)

  • 1. p53 reactivation kills KSHV lymphomas efficiently in vitro and in vivo: new hope for treating aggressive viral lymphomas.
    Sarek G; Ojala PM
    Cell Cycle; 2007 Sep; 6(18):2205-9. PubMed ID: 17890905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.
    Sarek G; Kurki S; Enbäck J; Iotzova G; Haas J; Laakkonen P; Laiho M; Ojala PM
    J Clin Invest; 2007 Apr; 117(4):1019-28. PubMed ID: 17364023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.
    Sarek G; Ma L; Enbäck J; Järviluoma A; Moreau P; Haas J; Gessain A; Koskinen PJ; Laakkonen P; Ojala PM
    Oncogene; 2013 Feb; 32(9):1091-8. PubMed ID: 22469985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma.
    Dai L; Cao Y; Chen Y; Parsons C; Qin Z
    J Hematol Oncol; 2014 Apr; 7():30. PubMed ID: 24708874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma.
    Carbone A; Gloghini A; Vaccher E; Cerri M; Gaidano G; Dalla-Favera R; Tirelli U
    J Mol Diagn; 2005 Feb; 7(1):17-27. PubMed ID: 15681470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas.
    Sarek G; Järviluoma A; Ojala PM
    Blood; 2006 Jan; 107(2):725-32. PubMed ID: 16160006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
    Viejo-Borbolla A; Schulz TF
    AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology.
    Gloghini A; Dolcetti R; Carbone A
    Semin Cancer Biol; 2013 Dec; 23(6):457-67. PubMed ID: 23999127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-herpesviruses and cellular signaling in AIDS-associated malignancies.
    Noguchi K; Fukazawa H; Murakami Y; Takahashi N; Yamagoe S; Uehara Y
    Cancer Sci; 2007 Sep; 98(9):1288-96. PubMed ID: 17640300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KSHV-Mediated Angiogenesis in Tumor Progression.
    Purushothaman P; Uppal T; Sarkar R; Verma SC
    Viruses; 2016 Jul; 8(7):. PubMed ID: 27447661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.
    Deloose ST; Smit LA; Pals FT; Kersten MJ; van Noesel CJ; Pals ST
    Leukemia; 2005 May; 19(5):851-5. PubMed ID: 15744337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology of AIDS-related Kaposi's sarcoma and lymphoma.
    Boshoff C; Whitby D; Talbot S; Weiss RA
    Oral Dis; 1997 May; 3 Suppl 1():S129-32. PubMed ID: 9456674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS-related lymphomas: from pathogenesis to pathology.
    Carbone A; Gloghini A
    Br J Haematol; 2005 Sep; 130(5):662-70. PubMed ID: 16115121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
    Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
    Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
    Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas.
    Järviluoma A; Koopal S; Räsänen S; Mäkelä TP; Ojala PM
    Blood; 2004 Nov; 104(10):3349-54. PubMed ID: 15271792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation.
    Merat R; Amara A; Lebbe C; de The H; Morel P; Saib A
    Int J Cancer; 2002 Feb; 97(6):791-5. PubMed ID: 11857356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.